MUNCO: Mucormycosis in COVID-19
Sponsor
Montefiore Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT04935463
Collaborator
Medanta Institute Delhi (Other), AIIMS Patna (Other), HCG Oncology Bangalore (Other), NSCB Jabalpur (Other)
728
1
9.2
78.9
Study Details
Study Description
Brief Summary
The purpose is to allow phsyician reporters to contribute to MUNCO registry. Mucormycosis in COVID-19 is a rapidly escalating medical emergency reported in high numbers in India during the ongoing coronavirus surge. There is very little known about the risk factors, patterns and complications of mucormycosis as it occurs either during the infection or treatment phase of the novel coronavirus (COVID-19). In light of this emerging epidemic within a pandemic, it is of time sensitive importance to obtain a better understanding of the risk factors and outcomes of this fatal complication
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
728 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Mucormycosis in COVID-19
Actual Study Start Date
:
May 24, 2021
Actual Primary Completion Date
:
Mar 1, 2022
Actual Study Completion Date
:
Mar 1, 2022
Outcome Measures
Primary Outcome Measures
- Vision loss [60 days]
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
Diagnosed case of Mycotic Infection in COVID-19
Exclusion Criteria:
- None
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Montefiore Medical Center | Bronx | New York | United States | 10467 |
Sponsors and Collaborators
- Montefiore Medical Center
- Medanta Institute Delhi
- AIIMS Patna
- HCG Oncology Bangalore
- NSCB Jabalpur
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Shitij Arora,
Associate Professor,
Montefiore Medical Center
ClinicalTrials.gov Identifier:
NCT04935463
Other Study ID Numbers:
- 2021-13086
First Posted:
Jun 23, 2021
Last Update Posted:
May 3, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: